Form4.ai tracks every SEC insider trade in real time. See every NRIX insider filing with a free account — no card.
See every NRIX insider filing — free account, no card.
Free accountNurix Therapeutics, Inc. (NRIX) has 8 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Nov. 2, 2026.
Open-market value, last 90 days
No open-market buys or sales in this period.
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Nov 2, 2026 SEC filing | van Houte Hans Chief Financial Officer | Vest & sell-to-cover | +7,348 sh | — |
| Nov 2, 2026 SEC filing | Ring Christine Chief Legal Officer | Vest & sell-to-cover | +6,225 sh | — |
| Nov 2, 2026 SEC filing | Hansen Gwenn Chief Scientific Officer | Vest & sell-to-cover | +6,225 sh | — |
Create a free account to see all 8 NRIX filings from the last 90 days. No card needed.
Create free accountWant NRIX insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.